Complement Component 5a (C5a), Recombinant, Human

Catalog Number: USB-045755
Article Name: Complement Component 5a (C5a), Recombinant, Human
Biozol Catalog Number: USB-045755
Supplier Catalog Number: 045755
Alternative Catalog Number: USB-045755-5,USB-045755-20
Manufacturer: US Biological
Category: Molekularbiologie
Complement 5a (C5a) is an enzymatically generated glycoprotein belonging to the anaphylatoxin family of structurally and functionally related proteins. Generated upon the activation of the complement system, C5a, together with C4a, C3a, and the membrane attack complex (C5b-9), functions as a central player in host defense by inducing smooth muscle cell contraction, increased vascular permeability, and histamine release from mast cells and basophilic leukocytes through cell degranulation. In addition to acting as a direct mediator of localized inflammatory response, C5a also initiates both the synthesis and release of IL-8 from monocytes and bronchial epithelial cells, stimulates the proliferation of neurons and hepatocytes, and functions as a potent chemoattractant. Where C5a deficiency, a rare defect of the complement pathway caused by the mutation of the C5a gene, is associated with susceptibility to severe infections, excessive C5a activation has been linked to liver fibrosis, sepsis, adult respiratory distress syndrome, rheumatoid arthritis, Alzheimers disease, and ischemic heart disease. Human C5a shares 60% and 54% sequence identity to mouse and rat C5a, respectively. The human C5 gene encodes a 1,676 amino acid glycoprotein that is comprised of a disulfide-linked C5 alpha and a C5 beta chain, the former of which contains the active, 74 amino acid C5a anaphylatoxin chain. Recombinant human C5a is an 8.3kD glycoprotein containing the 74 amino acid residues of the C5a anaphylatoxin chain. Recombinant protein corresponding to 74aa from human Complement Component 5a (C5a), expressed in E. coli. Biological Activity: Measured by its ability to support adhesion of Human Umbilical Vein Endothelial Cells (HUVEC) to the Recombinant Human C5a-coated surface. Amino Acid Sequence: TLQKKIEEIA AKYKHSVVKK CCYDGACVNN DETCEQRAAR ISLGPRCIKA FTECCVVASQ LRANISHKDM QLGR Storage and Stability: Lyophilized and reconstituted products are stable for 6 months after receipt at -20C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Molecular Weight: 8.3
UniProt: P01031
Purity: 98% (SDS-PAGE, HPLC). Endotoxin: 0.1ng/ug (<1EU/ug)
Form: Supplied as a lyophilized powder. Reconstitute to 1mg/ml with ddH2O, 0.1% BSA.